Corporate News 29-Jul-21
Alkem announces successful USFDA inspection of its Bioequivalence Center at Taloja
Alkem Laboratories announced that US FDA had conducted a remote and virtual Bio-Analytical inspection of the Company's Bioequivalence Center located at Taloja, Maharashtra from 26 July 2021 to 28 July 2021.
At the end of the inspection, no Form 483 was issued.
Previous News
Alkem Laboratories fixes record date for interim dividend
( Market Beat - Reports 01-Feb-24 19:30 )
Volumes spurt at Alkem Laboratories Ltd counter
( Hot Pursuit - 26-Apr-24 11:00 )
Alkem Laboratories to convene AGM
( Corporate News - 28-Jun-24 19:25 )
Alkem Laboratories Ltd soars 1.08%, Gains for third straight session
( Hot Pursuit - 28-Aug-24 13:05 )
Alkem Laboratories consolidated net profit rises 124.64% in the June 2023 quarter
( Results - Announcements 12-Aug-23 13:47 )
Alkem Lab PAT soars to Rs 294 cr in Q4
( Hot Pursuit - 29-May-24 15:45 )
Alkem Laboratories announces board meeting date
( Corporate News - 03-Nov-22 12:47 )
Alkem Laboratories
( Results - Analysis 11-Feb-23 21:38 )
Board of Alkem Laboratories appoints director
( Corporate News - 14-Sep-22 13:54 )
Alkem Laboratories appoints CFO
( Corporate News - 12-Jan-24 13:44 )
Alkem Laboratories fixes record date for interim dividend
( Market Beat - Reports 27-Jan-21 20:13 )
Other Stories
ITD Cementation India wins order of Rs 1,937 cr
03-Oct-24 10:35
NIIT Learning Systems allots 1,666 equity shares under ESOP
03-Oct-24 10:30
Ashoka Metcast to discuss results
03-Oct-24 10:29
Emerald Finance to declare Quarterly Result
03-Oct-24 10:29
Rhetan TMT schedules board meeting
03-Oct-24 10:29
Shrenik to table results
03-Oct-24 10:29
Universal Arts to declare Quarterly Result
03-Oct-24 10:28
Three M Paper Boards to conduct board meeting
03-Oct-24 10:28
Arkade Developers to declare Quarterly Result
03-Oct-24 10:28
Worth Investment & Trading Company announces board meeting date
03-Oct-24 10:28
Back
Top